The Technical Analyst
Select Language :
Lumos Pharma Inc [LUMO]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Lumos Pharma Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Lumos Pharma Inc is listed at the  Exchange

-1.38% $2.86

America/New_York / 28 mar 2024 @ 10:05


Lumos Pharma Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 23.19 mill
EPS: -4.18
P/E: -0.680
Earnings Date: Apr 30, 2024
SharesOutstanding: 8.11 mill
Avg Daily Volume: 0.0233 mill
RATING 2024-03-27
B-
Sell
RATINGS
Rating CashFlow: Strong Sell
Return On Equity: Strong Sell
Return On Asset: Sell
DE: Buy
P/E: Sell
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.680 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.12x
Company: PE -0.680 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 2.73 - 2.99

( +/- 4.51%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-01-04 Pitukcheewanont Pisit Duke Sell 0 Common Stock
2023-06-01 Pitukcheewanont Pisit Duke Sell 29 750 Stock Option (Right to Buy)
2024-02-01 Pitukcheewanont Pisit Duke Sell 3 333 Stock Option (Right to Buy)
2024-07-01 Pitukcheewanont Pisit Duke Sell 25 500 Stock Option (Right to Buy)
2023-08-01 Mckew John C. Sell 1 593 Common Stock
INSIDER POWER
23.92
Last 99 transactions
Buy: 596 623 | Sell: 145 033

Forecast: 11:45 - $2.90

Live Trading Signals (every 1 min)

Forecast 1: 10:15 - $2.84
Forecast 2: 11:05 - $2.90
Forecast 3: 11:45 - $2.90
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $2.86 (-1.38% )
Volume 0.0002 mill
Avg. Vol. 0.0233 mill
% of Avg. Vol 0.876 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Lumos Pharma Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Lumos Pharma Inc

RSI

Last 10 Buy & Sell Signals For LUMO

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Lumos Pharma Inc

LUMO

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare endocrine disorders. The company is headquartered in Austin, Texas.

Last 10 Buy Signals

Date Signal @
ARKMUSDMar 28 - 11:222.76
ZTUSDMar 28 - 11:13102.26
PZZAMar 28 - 11:2166.82
AGIUSDMar 28 - 11:210.449
WNEARUSDMar 28 - 11:197.28
WMNTUSDMar 28 - 11:201.200
SBACMar 28 - 11:20$218.00
ORDIUSDMar 28 - 11:1961.44
JOEUSDMar 28 - 11:180.904
INDEXUSDMar 28 - 11:195.97

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.